These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 19549053

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Comparing retention in treatment and mortality in people after initial entry to methadone and buprenorphine treatment.
    Bell J, Trinh L, Butler B, Randall D, Rubin G.
    Addiction; 2009 Jul; 104(7):1193-200. PubMed ID: 19563562
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
    Winstock AR, Lea T, Sheridan J.
    Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216
    [Abstract] [Full Text] [Related]

  • 9. Cycling in and out of treatment; participation in methadone treatment in NSW, 1990-2002.
    Bell J, Burrell T, Indig D, Gilmour S.
    Drug Alcohol Depend; 2006 Jan 04; 81(1):55-61. PubMed ID: 15993552
    [Abstract] [Full Text] [Related]

  • 10. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
    Ridge G, Gossop M, Lintzeris N, Witton J, Strang J.
    J Subst Abuse Treat; 2009 Jul 04; 37(1):95-100. PubMed ID: 19004598
    [Abstract] [Full Text] [Related]

  • 11. Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
    Digiusto E, Shakeshaft A, Ritter A, O'Brien S, Mattick RP, NEPOD Research Group.
    Addiction; 2004 Apr 04; 99(4):450-60. PubMed ID: 15049745
    [Abstract] [Full Text] [Related]

  • 12. Concurrent buprenorphine and benzodiazepines use and self-reported opioid toxicity in opioid substitution treatment.
    Nielsen S, Dietze P, Lee N, Dunlop A, Taylor D.
    Addiction; 2007 Apr 04; 102(4):616-22. PubMed ID: 17286641
    [Abstract] [Full Text] [Related]

  • 13. Maintenance therapy and 3-year outcome of opioid-dependent prisoners: a prospective study in France (2003-06).
    Marzo JN, Rotily M, Meroueh F, Varastet M, Hunault C, Obradovic I, Zin A.
    Addiction; 2009 Jul 04; 104(7):1233-40. PubMed ID: 19426291
    [Abstract] [Full Text] [Related]

  • 14. Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment.
    Winstock AR, Lea T, Sheridan J.
    Drug Alcohol Rev; 2008 Jul 04; 27(4):393-7. PubMed ID: 18584389
    [Abstract] [Full Text] [Related]

  • 15. The rise of buprenorphine prescribing in England: analysis of NHS regional data, 2001-03.
    de Wet CJ, Reed LJ, Bearn J.
    Addiction; 2005 Apr 04; 100(4):495-9. PubMed ID: 15784064
    [Abstract] [Full Text] [Related]

  • 16. Diversion and injection of methadone and buprenorphine among clients in public opioid treatment clinics in New South Wales, Australia.
    Winstock AR, Lea T.
    Subst Use Misuse; 2010 Apr 04; 45(1-2):240-52. PubMed ID: 20025451
    [Abstract] [Full Text] [Related]

  • 17. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ, Maynard C, Koepsell TD, Wells EA, Donovan DM.
    Addiction; 2009 May 04; 104(5):775-83. PubMed ID: 19344438
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bupreorphine:a new pharmacotherapy for opioid addictions treatment.
    Stock C, Shum JH.
    J Pain Palliat Care Pharmacother; 2004 May 04; 18(3):35-54. PubMed ID: 15364630
    [Abstract] [Full Text] [Related]

  • 20. Comparison of costs and utilization among buprenorphine and methadone patients.
    Barnett PG.
    Addiction; 2009 Jun 04; 104(6):982-92. PubMed ID: 19466922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.